A P-31-magnetic resonance spectroscopy and biochemical study of the mo(vbr) mouse: Potential model for the mitochondrial encephalomyopathies

被引:0
|
作者
Tracey, I [1 ]
Dunn, JF [1 ]
Radda, GK [1 ]
机构
[1] UNIV OXFORD,DEPT BIOCHEM,MRC,BIOCHEM & CLIN MAGNET RESONANCE UNIT,OXFORD OX1 3QU,ENGLAND
基金
英国惠康基金;
关键词
mitochondrial; encephalopathy; mo(vbr); P-31-magnetic resonance spectroscopy; muscle;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-31-magnetic resonance spectroscopy (P-31-MRS) provides new biochemical information on mitochondrial disorders affecting brain and muscle. To elucidate the mechanisms of mitochondrial abnormalities, however, animal models are needed, We assessed the mo(vbr) (mottled viable brindled) mouse for its value in studying (1) energetics of a mitochondrial disorder and (2) P-31-MRS changes associated with mitochondrial abnormalities in vivo. The maximal activity of succinate-cytochrome c reductase was significantly reduced in mo(vbr) muscle compared to controls, whereas cytochrome oxidase activity was only reduced in mo(vbr) brain, P-31-MRS of mo(vbr) brain showed an increased pH, but no changes in any metabolite ratios. The phosphocreatine (PCr) recovery rate after exercise was reduced in muscles from mo(vbr) mice, indicating impairment of oxidative metabolism. We conclude that mo(vbr) brain and muscle tissue have biochemical abnormalities consistent with mitochondrial impairment. The PCr recovery rate, measured by P-31-MRS, was sensitive to the muscle abnormality, This strain is best described as having chronic mitochondrial dysfunction. (C) 1997 John Wiley & Sons, Inc.
引用
收藏
页码:1352 / 1359
页数:8
相关论文
共 50 条
  • [41] IMPROVED NONINVASIVE DIAGNOSTIC TESTING FOR MALIGNANT HYPERTHERMIA SUSCEPTIBILITY FROM A COMBINATION OF METABOLITES DETERMINED INVIVO WITH P-31-MAGNETIC RESONANCE SPECTROSCOPY
    PAYEN, JF
    BOSSON, JL
    BOURDON, L
    JACQUOT, C
    LEBAS, JF
    STIEGLITZ, P
    BENABID, AL
    ANESTHESIOLOGY, 1993, 78 (05) : 848 - 855
  • [42] Study of myocardial metabolism by P-31 nuclear magnetic resonance spectroscopy
    Kasparova, S
    Dobrota, D
    Horecky, J
    BIOLOGIA, 1996, 51 (06) : 707 - 716
  • [43] P-31 MAGNETIC-RESONANCE SPECTROSCOPY MONITORING OF RADIOTHERAPY IN MOUSE-TUMORS
    MAXWELL, RJ
    BHUJWALLA, Z
    TOZER, GM
    GRIFFITHS, JR
    CLINICAL SCIENCE, 1986, 71 : P26 - P27
  • [44] Exercise and myotonic dystrophy:: A 31P magnetic resonance spectroscopy and magnetic resonance imaging case study
    Trenell, MI
    Thompson, CH
    Sue, CM
    ANNALS OF NEUROLOGY, 2006, 59 (05) : 871 - 872
  • [45] BIOCHEMICAL INVESTIGATION OF HUMAN-TUMORS INVIVO WITH P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    OBERHAENSLI, RD
    BORE, PJ
    RAMPLING, RP
    HILTONJONES, D
    HANDS, LJ
    RADDA, GK
    LANCET, 1986, 2 (8497): : 8 - 11
  • [46] Optimized cardiac graft preservation: A comparative experimental study using P-31 magnetic resonance spectroscopy and biochemical analyses
    Bernard, M
    Caus, T
    Sciaky, M
    Lan, C
    Cozzone, PJ
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (06): : 572 - 581
  • [47] Patterns of Parkinson Disease Mitochondrial Brain Function Indexed by 31P Magnetic Resonance Spectroscopy
    Lopez, F.
    Hess, C.
    Ray, A.
    O'Connell, R.
    O'Shea, A.
    Kenney, L.
    Ratajska, A.
    Alexander, G.
    Woods, A.
    Okun, M.
    Bowers, D.
    MOVEMENT DISORDERS, 2023, 38 : S696 - S697
  • [48] TREATMENT OF MITOCHONDRIAL ENCEPHALOMYOPATHY WITH RIBOFLAVIN AND NICOTINAMIDE MONITORED WITH P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    PENN, A
    LEE, J
    PERRY, T
    HALL, L
    MUSCLE & NERVE, 1988, 11 (09) : 984 - 984
  • [49] DIFFERENT EARLY EFFECT OF IRRADIATION IN BRAIN AND SMALL-CELL LUNG-CANCER EXAMINED BY INVIVO P-31-MAGNETIC RESONANCE SPECTROSCOPY
    KRISTJANSEN, PEG
    PEDERSEN, AG
    QUISTORFF, B
    SPANGTHOMSEN, M
    RADIOTHERAPY AND ONCOLOGY, 1992, 24 (03) : 186 - 190
  • [50] Brain activation in patients with mitochondrial disease without central nervous system involvement: A 31 P magnetic resonance spectroscopy study
    Bozzali, M
    Rango, M
    Prelle, A
    Comi, G
    Scarlato, G
    Bresolin, N
    NEUROLOGY, 1998, 50 (04) : A22 - A22